WA People
BILL · 2021–22 SESSION · LATEST VERSION SHB 1675

HB 1675: Dialysate & dialysis devices

Exempting a manufacturer of certain dialysate and dialysis devices used by home dialysis patients or a manufacturer's agent from the pharmacy practices act and legend drug act.

Summary

  • Requires that pharmacy and legend drug regulations allow manufacturers and wholesalers to sell, possess, deliver, or dispense dialysis devices and related legend drugs directly to home dialysis patients.

From the Substitute House Bill Report (SHB 1675), written by the Legislature's nonpartisan staff. Read the full report ↗

Enacted Enacted · Chapter 23, Laws of 2022
  1. IntroducedJan 10, 2022
  2. Out of committeeJan 20, 2022
  3. Passed HouseJan 26, 2022
  4. Passed SenateMar 1, 2022
  5. GovernorMar 11, 2022
  6. LawMar 11, 2022
Prime sponsor
Jessica Bateman (D-22)
Introduced
January 10, 2022 in the House
Last action
March 11, 2022
Session law
Chapter 23, Laws of 2022
Companion bill
SB 5507
Budget
Has a fiscal note
Versions
HB 1675, SHB 1675

AN ACT Relating to exempting a manufacturer of certain dialysate and dialysis devices used by home dialysis patients or a manufacturer's agent from the pharmacy practices act and legend drug act;

Sponsors

Prime sponsor: Jessica Bateman (D-22)

7 co-sponsors (4 Democrats, 3 Republicans)

Jacquelin Maycumber R-7Mari Leavitt D-28Jenny Graham R-6Laurie Dolan D-22Eileen Cody D-34Dan Griffey R-35Marcus Riccelli D-3

Votes

House · 3rd Reading & Final Passage

Passed January 26, 2022
Version voted on: SHB 1675
97 Yea 0 Nay 0 Absent 1 Excused
PartyYeaNayAbsentExcused
Democrat57000
Republican40001
How each member voted

Yea (97)

Excused (1)

Permalink to this vote

Senate · 3rd Reading & Final Passage

Passed March 1, 2022
Version voted on: SHB 1675
48 Yea 0 Nay 0 Absent 1 Excused
PartyYeaNayAbsentExcused
Democrat28001
Republican20000
How each member voted

Excused (1)

Permalink to this vote

History

  1. Effective date 6/9/2022. (SHB 1675)
  2. Chapter 23, 2022 Laws. (SHB 1675)
  3. Governor signed. (SHB 1675)
  4. Delivered to Governor. (SHB 1675)
  5. President signed. (SHB 1675)
  6. Speaker signed. (SHB 1675)
  7. Third reading, passed; yeas, 48; nays, 0; absent, 0; excused, 1. (SHB 1675)
  8. Rules suspended. Placed on Third Reading. (SHB 1675)
  9. Placed on second reading by Rules Committee. (SHB 1675)
  10. Passed to Rules Committee for second reading. (SHB 1675)
  11. HLTC - Majority; do pass. (SHB 1675)
  12. First reading, referred to Health & Long Term Care. (SHB 1675)
  13. Third reading, passed; yeas, 97; nays, 0; absent, 0; excused, 1. (SHB 1675)
  14. Rules suspended. Placed on Third Reading. (SHB 1675)
  15. 1st substitute bill substituted. (SHB 1675)
  16. 1st substitute bill substituted.
  17. Rules Committee relieved of further consideration. Placed on second reading. (SHB 1675)
  18. Rules Committee relieved of further consideration. Placed on second reading.
  19. Referred to Rules 2 Review. (SHB 1675)
  20. Referred to Rules 2 Review.
  21. HCW - Majority; 1st substitute bill be substituted, do pass. (SHB 1675)
  22. HCW - Majority; 1st substitute bill be substituted, do pass.
  23. HCW - Executive action taken by committee.
  24. First reading, referred to Health Care & Wellness.
  25. Prefiled for introduction.

HB 1675 in other sessions

Bill numbers restart every two years, so the same number is a different bill in each session.

Report wrong or missing information on this page